Automatic Cardiopulmonary Resuscitation (CPR) Devices Market Report 2026

The automatic CPR devices market size has grown rapidly in recent years. It will grow from $0.99 billion in 2025 to $1.11 billion in 2026 at a compound annual growth rate (CAGR) of 12%. The growth in the historic period can be attributed to growing incidence of cardiac arrest cases, increasing hospital and ems adoption of mechanical cpr devices, rising focus on improving resuscitation quality, expansion of emergency medical infrastructure and increasing preference for hands-free cpr during transport.

The automatic CPR devices market size is expected to see rapid growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing integration of automated cpr with aeds, growing investments in advanced life-support systems, rising adoption of robotic and electromechanical cpr technologies, expansion of critical-care equipment budgets in hospitals and increasing demand for consistent high-quality cpr performance. Major trends in the forecast period include technological advancements in automated cpr mechanisms, innovations in lightweight portable cpr devices, developments in real-time feedback and sensor analytics, research and development in ai-enabled compression optimization and advancements in connected and data-driven emergency response systems.

The increasing occurrence of cardiac arrest cases is expected to drive the expansion of the automatic cardiopulmonary resuscitation (CPR) devices sector in the coming years. Cardiac arrest is characterized by a sudden cessation of blood flow due to the heart’s inability to pump effectively, often resulting from an electrical malfunction in the heart. The rise in cardiac arrest cases is largely attributed to growing prevalence of heart disease, obesity, hypertension, and diabetes, all of which impair heart function and contribute to abnormal heart rhythms. Automatic cardiopulmonary resuscitation (CPR) devices assist in managing cardiac arrest cases by delivering continuous, precise chest compressions, ensuring effective blood circulation during emergencies. They enhance patient survival rates and outcomes by providing consistent resuscitation until advanced medical care is available. For example, in February 2025, Hato Hone St John, a New Zealand-based charitable organization offering ambulance services, reported that 2,547 people were treated for cardiac arrest in 2024, marking a 3.6 percent increase from 2023, with 72 percent of cases occurring at home. Consequently, the rising occurrence of cardiac arrest cases is fueling the growth of the automatic cardiopulmonary resuscitation (CPR) devices sector.

Leading companies in the automatic cardiopulmonary resuscitation (CPR) devices sector are concentrating on developing advanced solutions, such as automated mechanical CPR devices, to provide consistent resuscitation during critical air medical operations. Automated mechanical CPR devices are medical tools that deliver controlled, uniform chest compressions automatically during cardiopulmonary resuscitation. For example, in May 2025, Air Methods Corporation, a US-based air medical service provider, introduced the ZOLL AutoPulse NXT, an automated mechanical CPR device. The system is designed to provide uninterrupted compressions during patient loading and flight, featuring a compact, X-ray translucent design compatible with all aircraft in their fleet. Additionally, the solution supports ECMO and PCI-capable facility transport protocols, enhancing the quality of care for cardiac arrest patients and improving survival outcomes in emergency aeromedical situations.

In April 2023, Nordic Capital, a Sweden-based private equity firm focused on healthcare and technology investments, acquired a majority stake in corpuls GmbH for an undisclosed amount. With this acquisition, Nordic Capital intends to enhance corpuls GmbH’s portfolio of advanced resuscitation and critical care technologies, including automated cardiopulmonary resuscitation (CPR) devices, by providing strategic capital and growth resources to accelerate product development, global market reach, and clinical innovation. corpuls GmbH is a Germany-based medical technology company recognized for its emergency care solutions, patient monitoring systems, and automated CPR devices utilized by first responders and hospitals.

Major companies operating in the automatic cardiopulmonary resuscitation (cpr) devices market are Stryker Corporation, Mindray Bio-Medical Electronics Co. Ltd., ZOLL Medical Corporation, Nihon Kohden Corporation, Schiller AG, WEINMANN Emergency Medical Technology GmbH & Co. KG, Mediana Co. Ltd., Defibtech LLC, AAT Alber Antriebstechnik, GS Elektromedizinische Geräte G. Stemple GmbH, SunLife Science, Ambulanc Tech Co. Ltd., Michigan Instruments Inc., CPR Therapeutics Inc., Faith Biotech Co. Ltd., Inovytec Medical Solutions Ltd., Landswick Medical, Zhuhai Kindway Medical Science & Technology Co. Ltd., Shenzhen Bangvo Technology Co. Ltd., Beijing M&B Electronic Instruments Co. Ltd.

North America was the largest region in the automatic CPR devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automatic cardiopulmonary resuscitation (cpr) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automatic cardiopulmonary resuscitation (cpr) devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the automatic cpr devices market by increasing import costs of mechanical components and electronic modules, impacting the production and pricing of devices in key regions such as north america and europe. portable and high-end robotic cpr devices are most affected due to reliance on specialized imported parts. however, tariffs have also encouraged some manufacturers to localize production, innovate cost-effective designs, and explore alternative sourcing strategies, potentially boosting domestic manufacturing capabilities.

Automatic cardiopulmonary resuscitation (CPR) devices are mechanical systems engineered to provide automated, consistent chest compressions during cardiac arrest, replicating manual CPR without the limitations of human fatigue. They commonly utilize piston-based mechanisms, load-distributing bands, or pneumatic vests to ensure precise depth, rate, and recoil, thereby improving perfusion to vital organs. These devices improve the quality of resuscitation, enabling rescuers to concentrate on ventilation, defibrillation, or patient transport.

The main device types of automatic cardiopulmonary resuscitation devices include piston-based mechanical CPR systems, load-distributing band devices, pneumatic compression vests, active compression-decompression devices, and automated external defibrillators with CPR assistance. Piston-based systems deliver precise, consistent compressions to maintain circulation during cardiac arrest. These devices are available as portable or fixed units, using mechanical, electromechanical, or robotic technologies, and are applied in cardiac arrest, respiratory-related cardiac compromise, trauma-related arrest, post-surgical support, and multi-patient emergencies across hospitals, emergency services, ambulatory centers, public responder units, and home care settings.

The automatic cardiopulmonary resuscitation (CPR) devices market consists of sales of automated chest compression devices, mechanical CPR machines, portable resuscitation systems, and CPR feedback and monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.